$19.30
0.68% day before yesterday
NYSE, Dec 27, 09:50 pm CET
ISIN
US34965K1079
Symbol
FTRE

Fortrea Stock price

$19.36
-2.19 10.16% 1M
-3.52 15.38% 6M
-15.54 44.53% YTD
-15.89 45.08% 1Y
-10.74 35.68% 3Y
-10.74 35.68% 5Y
-10.74 35.68% 10Y
NYSE, Closing price Fri, Dec 27 2024
+0.19 0.99%
ISIN
US34965K1079
Symbol
FTRE
Sector
Industry

Key metrics

Market capitalization $1.74b
Enterprise Value $2.84b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 12.89
EV/Sales (TTM) EV/Sales 1.02
P/S ratio (TTM) P/S ratio 0.63
P/B ratio (TTM) P/B ratio 1.15
Revenue (TTM) Revenue $2.77b
EBIT (operating result TTM) EBIT $-86.90m
Free Cash Flow (TTM) Free Cash Flow $220.00m
Cash position $105.30m
EPS (TTM) EPS $-3.14
P/E forward negative
P/S forward 0.64
EV/Sales forward 1.05
Short interest 8.46%
Show more

Is Fortrea a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Fortrea Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Fortrea forecast:

2x Buy
15%
10x Hold
77%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a Fortrea forecast:

Buy
15%
Hold
77%
Sell
8%

Financial data from Fortrea

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,775 2,775
-
100%
- Direct Costs 2,350 2,350
-
85%
425 425
-
15%
- Selling and Administrative Expenses 423 423
-
15%
- Research and Development Expense - -
-
-
1.50 1.50
-
0%
- Depreciation and Amortization 88 88
-
3%
EBIT (Operating Income) EBIT -87 -87
-
-3%
Net Profit -280 -280
-
-10%

In millions USD.

Don't miss a Thing! We will send you all news about Fortrea directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Fortrea Stock News

Positive
Seeking Alpha
3 days ago
Fortrea, a recent Labcorp spin-off, is poised for recovery with strong bookings, industry inflection, and activist interest, despite a 46% stock drop in 2024. CEO Thomas Pike's proven track record and the potential January Effect add to Fortrea's upside, targeting a $45 stock price within a year. The CRO industry's temporary downturn is reversing, with Fortrea's book-to-bill ratio improving to ...
Neutral
GlobeNewsWire
about one month ago
DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Evercore HealthCONx Conference on Thursday, December 5, 2024 at 10:00 am ET.
Neutral
GlobeNewsWire
about one month ago
DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Citi Global Healthcare Conference on Wednesday, December 4, 2024 at 1:45 pm ET.
More Fortrea News

Company Profile

Fortrea Holdings, Inc. engages in the provision of clinical development and commercialization services. It operates under the Clinical Services and Enabling Services Segments. The Clinical Services segment provides services across the clinical pharmacology, clinical development, and other clinical service spectrum utilizing enabling services and technology through multiple delivery models. The Enabling Services segment provides technology solutions directly to customers that streamline complex randomization and optimize the trial drug supply process, while minimizing operational costs and supporting timely and accurate patient dosing. The company was founded on January 31, 2023 and is headquartered in Durham, NC.

Head office United States
CEO Thomas Pike
Employees 18,000
Founded 2023
Website fortrea.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today